Bridging the gap between discovery and clinical implementation in #cancer #immunotherapy #immunooncology at @HerlevGentofte Copenhagen. SoMe manager @doniamarco

Joined April 2018
72 Photos and videos
CCIT-DK: National Center for Cancer Immune Therapy retweeted
📣 Our new paper in @JNCCN: acquired resistance to #immunotherapy (ARI) across 11 tumor types Reconstructed IPD: 15,199 pts / 41 phase 3 trials • 73.5% develop ARI by 3y • Higher CR/PR → less ARI, regardless of tumor type ARI may be determined by response depth, not histology Cheers to @DoniaMarco & @CCITdk 🇩🇰 Full paper 👇👇👇
2
7
18
1,834
CCIT-DK: National Center for Cancer Immune Therapy retweeted
📣 New in #EJC: among PD-(L)1 responders, durability tracks response depth, not tumor type Our nationwide cohort 🇩🇰: 2,127 responders (#melanoma, #RCC, #NSCLC) • Within CR & within PR, PFS near-identical across tumors • PR vs CR = dominant factor Two papers, two faces of the same coin 🪙: response depth, not tumor type, drives the risk of acquired resistance to IO Trial-level (@JNCCN) real-world (#EJC), same conclusion Cheers to @DoniaMarco & @CCITdk Full paper 👇👇 #LCSM #IO
4
4
12
724
CCIT-DK: National Center for Cancer Immune Therapy retweeted
In a recent interview, @holmstrom_mo of @CCITdk discussed the potential of therapeutic cancer vaccines in MPNs, highlighting the challenges of integrating vaccine strategies into treatment. 💉🩸 Click here to watch the full interview: 🎥 👉 ow.ly/cBWP50YXv1I #ESHMPN2026 #MPNsm #ImmunoOnc #HemOnc
1
2
326
CCIT-DK: National Center for Cancer Immune Therapy retweeted
🆕 Nationwide real-world (DAMMED 🇩🇰) study comparing Dab/Tram vs Enco/Bini in 751 pts with BRAFm metastatic melanoma. ⚖️ No differences in efficacy 🧩 Consistent across subgroups (incl. 🧠 mets) 📄 doi.org/10.1093/jnci/djaf263 In @JNCI_Now @CCITdk @DoniaMarco #Melanoma #Oncology
3
2
8
1,046
@CCITdk is happy to support the candidacy of Professor @ulassen to this important post at ESMO @myESMO
28 May 2025
I am pleased and proud to be a candidate running in the election for the position of Nomination Committee Member for ESMO ESMO - @myESMO @Rigshospitalet @OECI_EEIG @ASCO esmo.org/about-esmo/how-we-w…
68
CCIT-DK: National Center for Cancer Immune Therapy retweeted
Acquired resistance to Cancer Immunotherapy Free at bit.ly/4jptfZz ➡️ Metastatic cancers can be cured ➡️ Pts who initially respond can develop resistance (up to 65% of responders) ❗One of the top priorities in Oncology Reviewed in @TrendsMolecMed @CCITdk @MdCurioni
2
1
5
250
CCIT-DK: National Center for Cancer Immune Therapy retweeted
New #JITC article: Arginase-1-specific T cells target and modulate tumor-associated macrophages bit.ly/3PZKkMP @marper2323 @CCITdk
3
12
1,096
🎉Cell Therapy Milestone 👍This week, a patient with melanoma received the first non-viral CRISPR-edited TIL infusion product at @CCITdk Congrats to Cell Therapy team @ozcan_met: from preclinical pubmed.ncbi.nlm.nih.gov/3514… to GMP grade clinicaltrials.gov/study/NCT…
2
3
194
CCIT-DK: National Center for Cancer Immune Therapy retweeted
📢 Check out this special case report by Monberg, Svane & colleagues @CCITdk @helsinkiuni @Rigshospitalet 🇩🇰🇫🇮. 💉Combined treatment with TILs oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma. Available #OpenAccess 👇esmoiotech.org/article/S2590…
2
3
487
📣 PhD course "Cancer Immunology and Immunotherapy", 4th edition 📃 Course Description and registration 👉bit.ly/40vh1YI ▶WHEN: 07-11/04/2025 (mon-fri) ▶WHERE: Copenhagen Area, Denmark 📩 Full program available soon! Previous edition at bit.ly/3CoqXcB
1
3
122
📢The Copenhagen Symposium on T Cell Therapy and Cellular Engineering (CATC) 2024 ⏰ 24-25 September 2024 📍 Greater Copenhagen, Denmark More at catc.dtu.dk/about
2
93
CCIT-DK: National Center for Cancer Immune Therapy retweeted
New publication on #MPNsm from @CCITdk published in @BrJHaem: Peripheral blood lymphocytes (PBL) from patients with CALR mutant #MPNsm display increased levels of surface TGFb and GARP. Probably mediated by enhanced binding of activated platelets to PBL. doi.org/10.1111/bjh.19711
3
12
514
📣 Webinar "Adoptive cell immunotherapies for cancer" SN Oncology Webinar Series on 14 May at 4 pm CEST by @SpringerNature 👉 Free registration at: cassyni.com/events/Y5qVZUYYn… 👩‍🔬 Speaker: Inge Marie Svane, Director of @CCITdk 👨‍🎓 Chair: Luca Danelli, Senior Editor @NatureComms
2
8
387
CCIT-DK: National Center for Cancer Immune Therapy retweeted
💬 Fantastic keynote lecture by Dr. Inge Marie Svane from @CCITdk on TIL therapies at VHIO under the framework of #PragamTIL Annual Meeting.
5
14
962
CCIT-DK: National Center for Cancer Immune Therapy retweeted
Despite manufacturing costs ~67 000 €, academic TIL therapy for patients with #melanoma is both cost-saving and cost-effective in 🇩🇰 and 🇱🇺 Publicly-funded #celltherapy can be sustainable!
New #JITC article: Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial bit.ly/3PG0IlP @DoniaMarco @tenHamR @HaanenJohn @ValescaRetel
5
28
2,601
CCIT-DK: National Center for Cancer Immune Therapy retweeted
Excited to share our latest article on @jitcancer, where we show that a TGFβ-based immune modulatory vaccine can both directly and indirectly modulate the phenotype of TAMs and CAFs, two high TGFβ-secreting cell subsets in the TME ➡ lnkd.in/dpyf9MPJ @CCITdk
1
4
12
1,772
CCIT-DK: National Center for Cancer Immune Therapy retweeted
New #JITC review: Biomarkers for response to TIL therapy: a comprehensive review bit.ly/43g4Yhe @Vic_albarran @pballestin @DoniaMarco
23
55
11,302
📣 The Neoantigen Based Cancer Vaccine Pipeline at Dana Farber Cancer Institute 👨‍⚕️ by Derin Keskin bit.ly/42KN3yY 🕰 March 8th 2024 at 9.15 📍 Auditorium H2, Herlev Hospital, DK 💻Online at bit.ly/4bK1Lug ‼️Join this seminar, No registration required‼️
2
195
🔬 Murine Models for Cancer Immunotherapy, an analysis of tumor microenvironment (TME) compositions 🐭 Insights into comparative roles of the Lymphoid, Myeloid, and Stromal cell compartments of these models from the TSMI group here in @CCITdk More at 👉 frontiersin.org/articles/10.…

1
2
164